Yu, W.-L.; Lee, N.-Y.; Wang, J.-T.; Ko, W.-C.; Ho, C.-H.; Chuang, Y.-C.
Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients. Antibiotics 2020, 9, 231.
https://doi.org/10.3390/antibiotics9050231
AMA Style
Yu W-L, Lee N-Y, Wang J-T, Ko W-C, Ho C-H, Chuang Y-C.
Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients. Antibiotics. 2020; 9(5):231.
https://doi.org/10.3390/antibiotics9050231
Chicago/Turabian Style
Yu, Wen-Liang, Nan-Yao Lee, Jann-Tay Wang, Wen-Chien Ko, Chung-Han Ho, and Yin-Ching Chuang.
2020. "Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients" Antibiotics 9, no. 5: 231.
https://doi.org/10.3390/antibiotics9050231
APA Style
Yu, W.-L., Lee, N.-Y., Wang, J.-T., Ko, W.-C., Ho, C.-H., & Chuang, Y.-C.
(2020). Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Critically Ill Patients. Antibiotics, 9(5), 231.
https://doi.org/10.3390/antibiotics9050231